Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Cell Reports|January 10, 2025
Isolation and structure of broad SIV-neutralizing antibodies reveal a proximal helical MPER epitope recognized by a rhesus multi-donor classJason Gorman, Renguang Du, Yen-Ting Lai, et al.Plos Pathogens|June 16, 2022
Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4Hugh C Welles, Hannah A D King, Leonard Nettey, et al.Frontiers in Immunology|April 7, 2023
Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamstersHannah A D King, Vincent Dussupt, Letzibeth Mendez-Rivera, et al.Proceedings of the National Academy of Sciences of the United States of America|January 30, 2025
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variantsHannah A D King, Daniel Brammer, Eric Lewitus, et al.Nature Medicine|October 2, 2023
AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaquesAmir Dashti, Sophia Sukkestad, Anna M Horner, et al.Journal of Virology|October 27, 2021
Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus MacaquesJingyou Yu, Natalie D Collins, Noe B Mercado, et al.Vaccines|May 28, 2022
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) ModelSara C Johnston, Keersten M Ricks, Ines Lakhal-Naouar, et al.Nature Communications|January 3, 2024
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaquesRajeshwer S Sankhala, Kerri G Lal, Jaime L Jensen, et al.Biorxiv : the Preprint Server for Biology|April 1, 2021
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman PrimatesMichael G Joyce, Hannah A D King, Ines Elakhal Naouar, et al.Proceedings of the National Academy of Sciences of the United States of America|September 2, 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaquesHannah A D King, M Gordon Joyce, Ines Lakhal-Naouar, et al.Pageof 3